Wanda Secures Funding for US Expansion
Deal News | Aug 05, 2025 | EMV Capital
Wanda Health, a portfolio company of EMV Capital, has successfully completed an investment round to further expand its platform in the US. The funding package, which includes a £250,000 loan, is intended to accelerate Wanda's commercial growth and advance its remote patient monitoring technology. With new contracts secured and partnerships formed, including with the COPD Foundation and American Heart Association, Wanda is strengthening its presence in the US market, particularly within the Pharmacy Benefit Managers segment. Wanda's current contracts aim for over £3.5 million in Annual Recurring Revenue, positioning the company for a Series A round in the future.
Sectors
- Healthcare Technology
- Investment and Venture Capital
Geography
- United States – Wanda Health is expanding its platform in the US market, securing key contracts and partnerships to penetrate the American healthcare sector.
- United Kingdom – EMV Capital, the private equity firm supporting Wanda Health, is based in the UK, indicating cross-border investment activities.
Industry
- Healthcare Technology – Wanda Health operates in the field of remote patient monitoring and virtual care, a key aspect of healthcare technology aiming to enhance patient care and health monitoring.
- Investment and Venture Capital – EMV Capital is a private equity firm investing in Wanda Health, reflecting the venture capital industry's role in supporting and scaling innovative businesses.
Financials
- £1.9m – The total closing amount for Wanda Health's investment round.
- £250,000 – Loan facility provided to Wanda Health for growth financing.
- $3.5m ARR – Projected Annual Recurring Revenue from existing contracts once fully onboarded.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Wanda Health | Target company | Company | Developer of an intelligent platform for remote patient monitoring and virtual care, expanding its market presence in the US. |
| EMV Capital | Private Equity investor | Company | The private equity firm leading the investment round to support Wanda Health's growth and expansion. |
| COPD Foundation | Partner | Charity | Partnered with Wanda Health to strengthen its position in key clinical focus areas. |
| American Heart Association | Partner | Charity | Partnered with Wanda Health to support its access to key clinical opinion leaders. |
| Sav-Rx | Pharmacy Benefit Manager | Company | A leading US Pharmacy Benefit Manager that has secured a contract with Wanda Health. |
| Dr. Ilian Iliev | Chairman and CEO | Person | Chairman of Wanda and CEO of EMV Capital, supporting Wanda's strategic growth. |